Compare TTK HEALTHCARE with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ABBOTT INDIA - Comparison Results

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE ABBOTT INDIA TTK HEALTHCARE/
ABBOTT INDIA
 
P/E (TTM) x 18.9 56.1 33.7% View Chart
P/BV x 1.5 13.5 11.2% View Chart
Dividend Yield % 1.0 0.5 200.7%  

Financials

 TTK HEALTHCARE   ABBOTT INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
ABBOTT INDIA
Mar-19
TTK HEALTHCARE/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,2158,834 13.8%   
Low Rs6105,458 11.2%   
Sales per share (Unadj.) Rs444.41,731.1 25.7%  
Earnings per share (Unadj.) Rs17.2211.9 8.1%  
Cash flow per share (Unadj.) Rs27.6219.9 12.6%  
Dividends per share (Unadj.) Rs5.0065.00 7.7%  
Dividend yield (eoy) %0.50.9 60.2%  
Book value per share (Unadj.) Rs177.9945.2 18.8%  
Shares outstanding (eoy) m14.1321.25 66.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.14.1 49.8%   
Avg P/E ratio x52.933.7 156.9%  
P/CF ratio (eoy) x33.032.5 101.6%  
Price / Book Value ratio x5.17.6 67.8%  
Dividend payout %29.030.7 94.5%   
Avg Mkt Cap Rs m12,894151,848 8.5%   
No. of employees `0002.33.5 66.3%   
Total wages/salary Rs m1,3074,356 30.0%   
Avg. sales/employee Rs Th2,715.710,555.5 25.7%   
Avg. wages/employee Rs Th565.31,249.9 45.2%   
Avg. net profit/employee Rs Th105.41,292.2 8.2%   
INCOME DATA
Net Sales Rs m6,27936,786 17.1%  
Other income Rs m781,133 6.8%   
Total revenues Rs m6,35637,919 16.8%   
Gross profit Rs m4966,047 8.2%  
Depreciation Rs m147169 86.7%   
Interest Rs m3423 150.2%   
Profit before tax Rs m3936,989 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1492,485 6.0%   
Profit after tax Rs m2444,503 5.4%  
Gross profit margin %7.916.4 48.0%  
Effective tax rate %37.935.6 106.7%   
Net profit margin %3.912.2 31.7%  
BALANCE SHEET DATA
Current assets Rs m2,71727,610 9.8%   
Current liabilities Rs m1,5718,569 18.3%   
Net working cap to sales %18.351.8 35.3%  
Current ratio x1.73.2 53.7%  
Inventory Days Days3260 53.4%  
Debtors Days Days4727 170.3%  
Net fixed assets Rs m9911,057 93.8%   
Share capital Rs m141213 66.5%   
"Free" reserves Rs m2,37319,873 11.9%   
Net worth Rs m2,51420,086 12.5%   
Long term debt Rs m30-   
Total assets Rs m4,15829,409 14.1%  
Interest coverage x12.6311.6 4.0%   
Debt to equity ratio x00-  
Sales to assets ratio x1.51.3 120.7%   
Return on assets %6.715.4 43.4%  
Return on equity %9.722.4 43.2%  
Return on capital %16.934.9 48.5%  
Exports to sales %3.60-   
Imports to sales %0.50-   
Exports (fob) Rs m225NA-   
Imports (cif) Rs m31NA-   
Fx inflow Rs m225369 61.0%   
Fx outflow Rs m714,918 1.4%   
Net fx Rs m154-4,549 -3.4%   
CASH FLOW
From Operations Rs m1734,991 3.5%  
From Investments Rs m97-2,570 -3.8%  
From Financial Activity Rs m-307-1,428 21.5%  
Net Cashflow Rs m-38993 -3.8%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 3.7 7.9 46.8%  
FIIs % 5.2 0.1 5,200.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 17.1 150.9%  
Shareholders   12,723 18,270 69.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   UNICHEM LAB  VENUS REMEDIES  STERLING BIOTECH  WOCKHARDT  AUROBINDO PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 334 Points Lower; Auto and Banking Stocks Witness Selling(Closing)

India share markets witnessed huge selling pressure today and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 334 points (down 0.8%).

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

TTK HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 38.0% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, TTK HEALTHCARE has posted a net profit of Rs 50 m (down 38.0% YoY). Sales on the other hand came in at Rs 1 bn (down 3.8% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Dec 6, 2019 03:31 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - SANOFI INDIA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS